BPH
49
6
7
23
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.2%
6 terminated out of 49 trials
79.3%
-7.2% vs benchmark
16%
8 trials in Phase 3/4
35%
8 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (49)
Effect of Group Preoperative Pelvic Floor Training for HoLEP
HoLEP Sexual Survivorship
Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL)
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia
High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction
INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms
Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate
US Imaging for the Assessment of LUTS
Data Collection Post Radical Prostatectomy
Blue Diode Laser Vaporization for BPH
Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.
SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia
Evaluation of SureCore Plus Biopsy System
Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients.
Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity
Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia
MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)
5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression
Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP